Punica Granatum Root Bark

There is no standardized oral adult dosage for Punica Granatum Root Bark in modern conventional medicine due to its high toxicity profile. In diagnostic allergy settings, the dosage is determined by the concentration of the extract (e.g., 1:10 w/v or 1:100 w/v) and is administered in minute quantities (microliters) during skin testing.

Historically, decoctions were made using 60 grams of fresh bark in 600 mL of water, boiled down to 300 mL. This was administered in divided doses over several hours. However, this practice is considered obsolete and dangerous by modern standards.

Punica Granatum Root Bark is generally not approved for pediatric use in an internal capacity. Children are significantly more susceptible to the neurotoxic effects of pelletierine alkaloids. In allergy testing, pediatric use must be performed by a board-certified allergist using highly diluted, standardized extracts.

Renal Impairment

Because the alkaloids and their metabolites are cleared renally, individuals with a Glomerular Filtration Rate (GFR) below 60 mL/min are at a significantly increased risk of systemic toxicity if any absorption occurs. No established guidelines exist for dose adjustment; therefore, use is generally avoided.

Hepatic Impairment

Patients with hepatic impairment (Child-Pugh Class B or C) may experience reduced metabolism of the bark's alkaloids, leading to prolonged circulation and increased risk of central nervous system effects.

Elderly Patients

Elderly patients are at a higher risk for adverse reactions due to potential age-related declines in renal function and a higher prevalence of polypharmacy, which increases the risk of drug-drug interactions with the bark's tannins and polyphenols.

If being used for diagnostic allergy testing:

• The procedure must be performed in a clinical setting equipped with emergency resuscitation equipment (e.g., epinephrine, oxygen).
• The skin (usually the forearm or back) is cleaned with alcohol.
• A drop of the extract is placed on the skin, and a sterile lancet is used to prick the surface.
• The site is observed for 15-20 minutes for a wheal-and-flare reaction.

For historical or traditional preparations (if prescribed by a specialist):

• It should be taken on an empty stomach.
• It is often followed by a saline purgative (like magnesium sulfate) two hours later to ensure the paralyzed worms and the toxic bark alkaloids are expelled from the body quickly.

In the context of diagnostic testing, a missed appointment should be rescheduled. For any other prescribed use, do not double the dose to catch up, as this significantly increases the risk of alkaloid poisoning. If a dose is missed, contact your healthcare provider for instructions.

Signs of Punica Granatum Root Bark overdose (Pelletierine poisoning) include:

• Severe dizziness and vertigo
• Blurred vision or temporary blindness
• Intense nausea and projectile vomiting
• Muscle tremors and weakness
• Respiratory depression
• Convulsions

In the event of a suspected overdose, call 911 or your local emergency services immediately. Gastric lavage and supportive care for respiratory function are typically required.

> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or attempt to prepare home remedies from Punica Granatum Root Bark without medical guidance.

When administered orally (as in traditional or historical contexts), the most common side effects are gastrointestinal and neurological in nature:

• Nausea: A persistent feeling of stomach upset that typically begins within 30 minutes of ingestion.
• Dizziness: A sensation of lightheadedness or vertigo that may make standing or walking difficult.
• Abdominal Cramping: Sharp or dull pains in the midsection as the tannins and alkaloids interact with the intestinal lining.

• Visual Disturbances: Patients may report a yellowish tint to their vision (xanthopsia), blurring, or increased sensitivity to light.
• Vomiting: This is often a sign that the body is attempting to reject the toxic alkaloids.
• Headache: Dull, throbbing pain, often localized to the frontal region.
• Drowsiness: A significant state of lethargy or sedation.

• Muscle Tremors: Involuntary shaking of the limbs, indicating central nervous system irritation.
• Mydriasis: Persistent dilation of the pupils.
• Urticaria: Hives or an itchy rash, indicating an allergic reaction to the bark proteins.

> Warning: Stop using Punica Granatum Root Bark and call your doctor immediately if you experience any of the following:

• Anaphylaxis: Symptoms include swelling of the face, tongue, or throat; difficulty breathing; and a rapid drop in blood pressure. This is a life-threatening emergency.
• Temporary Blindness: A complete loss of vision that may occur due to the toxic effect of pelletierine on the optic nerve.
• Convulsions: Seizure activity or uncontrollable muscle contractions.
• Respiratory Paralysis: A feeling of being unable to take a breath or extreme shortness of breath, which can lead to respiratory failure.
• Severe Bradycardia: An abnormally slow heart rate that may cause fainting or chest pain.

Because Punica Granatum Root Bark is not intended for chronic use, long-term data is sparse. However, repeated exposure to high tannin concentrations can lead to chronic constipation and potential irritation of the gastric mucosa. There is also a theoretical risk of chronic nephrotoxicity if the alkaloids are consumed repeatedly over time.

Currently, the FDA has not issued a formal Black Box Warning for Punica Granatum Root Bark extracts used in diagnostic testing. However, historical medical literature consistently warns that the root bark should be treated as a potent poison with a very narrow therapeutic window. The risk of neurotoxicity and respiratory failure is the primary concern for any internal consumption.

Report any unusual symptoms or side effects to your healthcare provider or through the FDA MedWatch program.

Punica Granatum Root Bark contains alkaloids that are chemically related to nicotine and are potent neurotoxins. This substance should never be used as a dietary supplement or home remedy without direct medical supervision. Its use in 2026 is largely restricted to controlled diagnostic environments.

No FDA black box warnings for Punica Granatum Root Bark are currently active for its use as an allergenic extract. However, practitioners must be aware of the inherent toxicity of the raw botanical material.

• Allergic Reactions / Anaphylaxis Risk: As an allergenic extract, the primary risk is a systemic allergic reaction. Patients with a known history of severe fruit allergies (particularly to pomegranate, peach, or apple) must be monitored with extreme caution during testing.
• Neurotoxicity: The pelletierine alkaloids can cause significant central nervous system depression and visual impairment. This risk is heightened in patients with pre-existing neurological conditions or those taking other CNS depressants.
• Gastrointestinal Sensitivity: Patients with active peptic ulcer disease or inflammatory bowel disease (IBD) should avoid internal use of the bark, as the high tannin content (up to 25%) can cause severe mucosal irritation.
• Optic Nerve Sensitivity: There is a specific risk of toxic amblyopia (vision loss) associated with the alkaloids in the bark. Any change in vision requires immediate cessation of use and an ophthalmological evaluation.

If a patient is undergoing a procedure involving Punica Granatum Root Bark or is using it under a specialized protocol, the following may be monitored:

• Visual Acuity: Baseline and follow-up eye exams to check for optic nerve irritation.
• Respiratory Function: Monitoring for signs of respiratory depression or distress.
• Vital Signs: Continuous monitoring of heart rate and blood pressure during allergenic testing to detect early signs of anaphylaxis.

Do not drive or operate heavy machinery after the administration of Punica Granatum Root Bark if you experience dizziness, blurred vision, or drowsiness. These effects can significantly impair your reaction time and coordination.

Alcohol should be avoided when using Punica Granatum Root Bark. Alcohol can potentiate the neurotoxic effects of the alkaloids and may increase the absorption of toxins through the gastric mucosa, leading to a higher risk of systemic poisoning.

There are no known withdrawal symptoms associated with the discontinuation of Punica Granatum Root Bark, as it is not used for long-term therapy. However, if being used to treat a parasitic infection (in rare, specialized cases), the full course must be completed as directed to ensure the parasite is fully eradicated.

> Important: Discuss all your medical conditions, especially any history of seizures or vision problems, with your healthcare provider before starting Punica Granatum Root Bark.

• Other Anthelmintics (e.g., Santonin): Combining Punica Granatum Root Bark with other older anthelmintics like santonin is strictly contraindicated. The combination can lead to additive neurotoxicity, resulting in severe convulsions and permanent visual damage.
• MAO Inhibitors (MAOIs): There is a theoretical risk that the alkaloids in the bark could interact with MAOIs, leading to unpredictable changes in blood pressure or CNS excitation.

• CNS Depressants (Benzodiazepines, Opioids): Punica Granatum Root Bark can enhance the sedative and respiratory-depressant effects of these medications. Patients should be monitored for extreme lethargy and slowed breathing.
• Antihypertensives: The bark may either potentiate or interfere with the action of blood pressure medications, depending on the individual's autonomic response to the alkaloids.

• Oral Medications (General): Because the bark is extremely high in tannins, it can bind to a wide variety of oral medications in the stomach, preventing their absorption. It is generally recommended to take other medications at least 2 hours before or 4 hours after any oral bark preparation.
• CYP3A4 Substrates: Pomegranate compounds are known inhibitors of the CYP3A4 enzyme. This can increase the blood levels of drugs like simvastatin, buspirone, and certain calcium channel blockers, potentially leading to toxicity.

• Fats and Oils: Historically, it was advised to avoid fats and oils (including castor oil) when taking the bark for parasites. Fats can increase the solubility and absorption of the toxic alkaloids, leading to systemic poisoning rather than localized action in the gut.
• Grapefruit Juice: Like pomegranate, grapefruit juice inhibits CYP3A4. Combining them can lead to a significant reduction in drug metabolism for shared pathways.

• Tannin-Rich Herbs (Witch Hazel, Oak Bark): Using other herbs high in tannins can increase the risk of severe constipation and stomach irritation.
• St. John's Wort: May interact with the metabolic pathways of the bark's alkaloids, though specific data is limited.

• Skin Prick Tests: The use of antihistamines (like loratadine or diphenhydramine) within 48-72 hours of using Punica Granatum Root Bark for allergy testing will cause a false-negative result.
• Urinary Alkaloid Screens: The presence of pelletierine may interfere with certain toxicology screens or specialized alkaloid tests.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including those for allergies or parasites.

Punica Granatum Root Bark must NEVER be used in the following circumstances:

• Pregnancy: The bark contains compounds that can act as uterine stimulants. Historically, it has been used as an abortifacient, and its use during pregnancy poses a severe risk of miscarriage and fetal toxicity.
• Severe Renal Disease: Patients with kidney failure cannot effectively clear the alkaloids, leading to a high risk of lethal neurotoxicity.
• Active Peptic Ulcers: The high tannin content is extremely irritating to the gastric mucosa and can cause bleeding or perforation in patients with existing ulcers.
• Hypersensitivity: Any known previous severe reaction to pomegranate or its components.

Conditions requiring careful risk-benefit analysis by a healthcare provider:

• History of Seizures: The alkaloids may lower the seizure threshold.
• Cardiac Arrhythmias: The potential for bradycardia or autonomic nervous system effects makes this a high-risk substance for heart patients.
• Constipation: The astringent nature of the bark can severely worsen existing bowel obstruction or chronic constipation.

Patients who are allergic to other members of the Lythraceae family or those with known allergies to birch pollen may show cross-sensitivity to Punica Granatum Root Bark extracts during diagnostic testing.

> Important: Your healthcare provider will evaluate your complete medical history, including any history of gastrointestinal or neurological disease, before prescribing or using Punica Granatum Root Bark.

Punica Granatum Root Bark is classified as Category X for internal use during pregnancy. It is strictly contraindicated. The bark contains pelletierine and tannins that can induce uterine contractions and have been historically linked to pregnancy termination. Furthermore, the neurotoxic alkaloids can cross the placental barrier, posing a significant risk of teratogenicity or fetal death. There is no clinical scenario where the internal use of the root bark outweighs the risk to the fetus.

It is unknown if the alkaloids from Punica Granatum Root Bark pass into human breast milk. However, given the low molecular weight of pelletierine, passage is highly likely. Due to the extreme sensitivity of the infant nervous system to alkaloids, breastfeeding is not recommended if the mother has ingested the bark. For diagnostic skin testing, the systemic absorption is generally considered negligible, but a consultation with a lactation specialist is advised.

Internal use of Punica Granatum Root Bark in children is dangerous and not recommended. Pediatric patients have a much higher surface-area-to-volume ratio and immature metabolic pathways, making them highly susceptible to respiratory failure and convulsions from even small doses of pelletierine. In allergy clinics, use is restricted to diagnostic testing under the supervision of a pediatric allergist.

Elderly patients (65 years and older) should be treated with extreme caution. This population often has reduced renal clearance and may be taking multiple medications that interact with the bark's tannins. There is an increased risk of falls due to the dizziness and vertigo associated with the bark's alkaloids. If used for diagnostic testing, the skin of elderly patients may be thinner, potentially affecting the interpretation of the skin prick test.

In patients with moderate to severe renal impairment (CrCl < 30 mL/min), the excretion of pelletierine metabolites is significantly delayed. This can lead to a build-up of toxins in the blood, resulting in prolonged neurological symptoms. Internal use is generally avoided in this population.

Patients with cirrhosis or other forms of hepatic impairment may have reduced ability to metabolize the polyphenolic compounds and alkaloids in the bark. This can increase the systemic bioavailability of the toxins. Close monitoring for signs of encephalopathy or increased sedation is required if any exposure occurs.

> Important: Special populations require individualized medical assessment and often require safer alternatives to Punica Granatum Root Bark.

The primary active constituents of Punica Granatum Root Bark are the punicine (pelletierine) alkaloids. These nitrogenous compounds act as agonists at the nicotinic acetylcholine receptors (nAChRs) located at the neuromuscular junction of various helminths (parasitic worms). By binding to these receptors, the alkaloids induce a state of persistent muscular depolarization, leading to spastic paralysis of the parasite. This paralysis prevents the worm from maintaining its attachment to the host's intestinal wall, allowing it to be expelled via peristalsis or a purgative.

In humans, at higher doses, these same alkaloids can interact with nicotinic receptors in the central and peripheral nervous systems, leading to the observed toxic effects such as tremors, mydriasis, and respiratory depression.

• Onset of Action: For anthelmintic effects, onset occurs within 1-2 hours of ingestion. For allergenic skin testing, the inflammatory response (wheal and flare) typically peaks at 15-20 minutes.
• Duration of Effect: The paralytic effect on parasites is temporary; if the worm is not expelled, it may recover as the alkaloid concentration declines. In humans, the neurological side effects can last for 6-12 hours.
• Tolerance: There is no evidence of pharmacological tolerance development, as the substance is not intended for chronic use.

| Parameter | Value |

|---|---|

| Bioavailability | Variable (highly dependent on tannin concentration) |

| Protein Binding | Unknown in humans; high affinity for proteins (tannins) |

| Half-life | Estimated 2-4 hours (alkaloids) |

| Tmax | 1-1.5 hours post-ingestion |

| Metabolism | Hepatic (Primary) |

| Excretion | Renal (Major), Fecal (Minor) |

• Molecular Formula: C8H15NO (Pelletierine)
• Molecular Weight: 141.21 g/mol (Pelletierine)
• Solubility: Alkaloids are soluble in water and alcohol; tannins are highly water-soluble.
• Description: The root bark is typically yellowish-grey on the outer surface and smooth, yellowish on the inner surface. It has a short, granular fracture and a bitter, astringent taste.

Punica Granatum Root Bark is categorized as a botanical anthelmintic and an allergenic extract. It belongs to the broader therapeutic class of anti-parasitic agents and diagnostic allergens.